TransMedics (TMDX) News

Analyst Reiterates Buy on TransMedics as U.S. Transplant Volumes Accelerate and Aviation Utilization Supports Sustained Growth

TipRanksSep 3 15:45

Most Shorted Stocks on Wall Street

Seeking AlphaSep 2 22:28

Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90

Piper Sandler analyst Matthew O'Brien maintains $TransMedics(TMDX.US)$ with a buy rating, and adjusts the target price from $100 to $90.According to TipRanks data, the analyst has a success rate of 40

Futu NewsSep 2 19:34

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Medtronic (MDT) and AbCellera Biologics (ABCL)

TipRanksSep 2 19:30

TransMedics to Present at Upcoming September Investor Conferences

ANDOVER, Mass., Aug. 31, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-

PR NewswireSep 1 04:05

Oppenheimer Maintains TransMedics(TMDX.US) With Hold Rating

Oppenheimer analyst Suraj Kalia maintains $TransMedics(TMDX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 50.8% and a total average return of 7.9% over the

Futu NewsAug 24 22:33

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and NeoGenomics (NEO)

TipRanksAug 24 22:10

TransMedics Group Ramps Growth With Record Earnings

TipRanksAug 17 08:18

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TipRanksAug 13 23:40

CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $95

CCORF analyst William Plovanic maintains $TransMedics(TMDX.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 47.3% and a

Futu NewsAug 12 20:34

TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook

TipRanksAug 12 19:35

Piper Sandler Reiterates Overweight on TransMedics Group, Lowers Price Target to $100

Piper Sandler analyst Matt O'Brien reiterates TransMedics Group (NASDAQ:TMDX) with a Overweight and lowers the price target from $120 to $100.

BenzingaAug 6 00:02

Mid-cap Sell Streak: Stocks Trapped Longest in Bearish Quant Ratings

Seeking AlphaAug 5 23:12

UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating

TransMedics Group (TMDX) has an average rating of overweight and mean price target of $97.30, according to analysts polled by FactSet.

MT NewswiresAug 5 21:15

A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $95 to $122

On Aug 05, major Wall Street analysts update their ratings for $TransMedics(TMDX.US)$, with price targets ranging from $95 to $122.TD Cowen analyst Josh Jennings maintains with a buy rating, and

Futu NewsAug 5 21:00

SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Wednesday.Shares of Space Exploration Technologies Corp (NASDAQ:SPCX) fell sharply in pre-market trading

BenzingaAug 5 20:03

At a Glance: Stocks Gapping Down Premarket

Seeking AlphaAug 5 19:32

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Addus Homecare (ADUS) and Henry Schein (HSIC)

TipRanksAug 5 19:31

Express News | Transmedics Group, Inc. : Stifel Cuts Target Price to $65 From $80

BreakingsAug 5 19:16

Express News | Transmedics Group, Inc. : Canaccord Genuity Cuts Target Price to $95 From $124

BreakingsAug 5 13:33